<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03552939</url>
  </required_header>
  <id_info>
    <org_study_id>639226</org_study_id>
    <nct_id>NCT03552939</nct_id>
  </id_info>
  <brief_title>The Impact of Maternal Microbes on Infant Health Programming</brief_title>
  <acronym>MAMI</acronym>
  <official_title>The Power of Maternal Microbes on Infant Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Agrochemistry and Food Technology, National Research Council</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundación para la Investigación del Hospital Clínico de Valencia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario La Fe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital de Manises</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CS Serreria II</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CS La Eliana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institute of Agrochemistry and Food Technology, National Research Council</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      MAMI aims to characterize maternal microbes to be transferred to neonates and determine their
      function in infant health programming.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent reports suggest that early microbial colonization has an important role for in
      promoting health. This may contribute to reduce the risk of chronic diseases such as obesity,
      allergies and inflammatory conditions. Advances in understanding host-microbe interactions
      imply that maternal microbiota plays a crucial role on health programming. This process
      begins in utero and it is modulated by mode of delivery and diet. The investigator's previous
      data has shown that i) specific shifts in milk microbial composition are associated with
      lactation time and mode of delivery, ii) milk microbes drive the infant microbiota
      composition; iii) maternal microbiota dysbiosis may be transferred to the infant. However,
      factors defining maternal microbiota and its biological role upon infant's health are not yet
      fully understood. Hence, this project aims to characterize maternal microbes to be
      transferred to neonates and determine their function in infant health programming. The
      specific aims are:(1) understanding how the maternal microbiome is influenced by host and
      environmental factors;(2) characterizing the microbial core and bioactive compounds
      transmitted to the offspring mainly via breastfeeding and their key roles in the microbial
      modulation and host response;(3) understanding the interactions among breast milk bioactive
      compounds and their role in infant health;(4) shedding light on how maternal microbes
      influence the infant immune system.

      Results obtained will demonstrate the interaction between infant nutrition, microbes and host
      response in early life and its key role in health programming, enabling new applications in
      the field of personalized nutrition &amp; medicine.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Microbiota composition</measure>
    <time_frame>from birth to 24 month</time_frame>
    <description>Dominant microbial species maternal and infant samples (using qPCR and sequencing -approaches analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal diet</measure>
    <time_frame>from birth to12 month</time_frame>
    <description>Maternal diet (FFQ) during gestation and 12 month post-partum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal BMI</measure>
    <time_frame>pre-gestational</time_frame>
    <description>To check Body Mass Index (kg/cm2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal weight</measure>
    <time_frame>pre-gestational and from birth to 12 months post-partum</time_frame>
    <description>To check Weight gain over pregnancy (kg) and weight during lactation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify maternal factors affecting microbiota: antibiotics</measure>
    <time_frame>pre-gestational</time_frame>
    <description>antibiotics treatment during gestation (number of treatments)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify the impact of mode of delivery</measure>
    <time_frame>Birth</time_frame>
    <description>Mode of delivery type: Vaginal/C-section (elective or non-elective)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant weight</measure>
    <time_frame>from birth to 24 month</time_frame>
    <description>Infant weight (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant height</measure>
    <time_frame>from birth to 24 month</time_frame>
    <description>Infant height (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant Diet</measure>
    <time_frame>from bith to 24 month</time_frame>
    <description>Exclusive breastfeeding time (months), breastfeeding duration and time of introduction of complementary food</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal short-chain fatty acids</measure>
    <time_frame>from birth to 24 month</time_frame>
    <description>Determine the relationship between fecal microbiota composition and fecal short chain fatty acids</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Healthy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Families located on the Mediterranean area
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt; 18 years.

          -  Healthy woman (no medication, no diabetes, no pre-gestational thyroid problems)

          -  Postpartum woman (beginning of the puerperium).

        Exclusion criteria:

          -  Non-compliance with any of the inclusion criteria.

          -  Medication and drugs

          -  Health problems at the immunological and metabolic levels.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>women (pregnant women)</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fundacion Investigacion Sanitaria INCLIVA</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politecnico la Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Boix-Amorós A, Martinez-Costa C, Querol A, Collado MC, Mira A. Multiple Approaches Detect the Presence of Fungi in Human Breastmilk Samples from Healthy Mothers. Sci Rep. 2017 Oct 12;7(1):13016. doi: 10.1038/s41598-017-13270-x. Erratum in: Sci Rep. 2018 Nov 9;8(1):16829.</citation>
    <PMID>29026146</PMID>
  </results_reference>
  <results_reference>
    <citation>Gómez-Gallego C, Kumar H, García-Mantrana I, du Toit E, Suomela JP, Linderborg KM, Zhang Y, Isolauri E, Yang B, Salminen S, Collado MC. Breast Milk Polyamines and Microbiota Interactions: Impact of Mode of Delivery and Geographical Location. Ann Nutr Metab. 2017;70(3):184-190. doi: 10.1159/000457134. Epub 2017 Mar 17.</citation>
    <PMID>28301837</PMID>
  </results_reference>
  <results_reference>
    <citation>Kumar H, du Toit E, Kulkarni A, Aakko J, Linderborg KM, Zhang Y, Nicol MP, Isolauri E, Yang B, Collado MC, Salminen S. Distinct Patterns in Human Milk Microbiota and Fatty Acid Profiles Across Specific Geographic Locations. Front Microbiol. 2016 Oct 13;7:1619. eCollection 2016.</citation>
    <PMID>27790209</PMID>
  </results_reference>
  <results_reference>
    <citation>Boix-Amorós A, Collado MC, Mira A. Relationship between Milk Microbiota, Bacterial Load, Macronutrients, and Human Cells during Lactation. Front Microbiol. 2016 Apr 20;7:492. doi: 10.3389/fmicb.2016.00492. eCollection 2016.</citation>
    <PMID>27148183</PMID>
  </results_reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>March 21, 2018</study_first_submitted>
  <study_first_submitted_qc>June 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2018</study_first_posted>
  <last_update_submitted>February 25, 2019</last_update_submitted>
  <last_update_submitted_qc>February 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institute of Agrochemistry and Food Technology, National Research Council</investigator_affiliation>
    <investigator_full_name>Maria Carmen Collado</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>microbiota</keyword>
  <keyword>breast milk</keyword>
  <keyword>diet</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

